Title: Tofogliflozin: first global approval.
Journal: Drugs 20140601
Title: Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
Journal: Journal of medicinal chemistry 20120913
Title: Tofogliflozin, a potent and highly specific sodium/glucose cotransporter 2 inhibitor, improves glycemic control in diabetic rats and mice.
Journal: The Journal of pharmacology and experimental therapeutics 20120601
Title: [Research progress of sodium-glucose co-transporter 2 inhibitors for treatment of type 2 diabetes].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20120601